How can we, humans, look at our relationship to nature differently? In season three of Going Wild, on top of stories about animals, we invite you to journey through the entire ecological web — from the tiniest of life forms to apex predators — alongside the scientists, activists and adventurers who study it. Wildlife biologist and host Dr. Rae Wynn-Grant has been studying wild animals in their natural habitats all over the world for years. Our award-winning podcast takes you inside the hidde ...
…
continue reading
Treść dostarczona przez Jon Chee. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez Jon Chee lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.
Player FM - aplikacja do podcastów
Przejdź do trybu offline z Player FM !
Przejdź do trybu offline z Player FM !
🧬 David Li - Meliora Therapeutics - Part 3 | Developing a Blood-Based Lung Cancer Test | The Rifle-Shot Nature of Biotech | Software Vs. Biotech Product Market Fit | The Super Power all Startups Need
MP3•Źródło odcinka
Manage episode 427933279 series 3461709
Treść dostarczona przez Jon Chee. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez Jon Chee lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.
Part 3 of 4.
My guest for this week’s episode is David Li, CEO and co-founder of Meliora Therapeutics. Meliora's goal is to develop life-saving cancer therapies using cutting-edge science and machine learning. The company derives a comprehensive picture of how drugs interact with cancer biology by combining biofunctional readouts from numerous modalities using advanced machine learning and other computational techniques.
Before Meliora, David served as Chief Business Officer at Everest Detection, an early detection liquid biopsy startup, and was head of commercial operations at Benchling, a life sciences software platform company which has achieved a $6 billion valuation and has attracted over $500 million in funding from firms such as Altimeter Capital, Tiger Global, Lone Pine Capital, Benchmark, Sequoia, Excel, Lux, and numerous others. David began his career in Goldman Sachs Healthcare Investment Banking Group and KKR's Private Equity Group, where he advised and invested in transactions worth over $10 billion in enterprise value. David's multifaceted experiences in the financial and life science sectors give him a wide range of experiences that founders can learn from.
Join us this week and hear about:
- Working at Everest Detection and developing a blood-based lung cancer test
- Excelling in a non-iterative work environment
- How software and biotech companies think about product market fit differently
- Why money is a super power for biotech startups today
- And much more!
Please enjoy my conversation with David Li.
Timestamps:
Timestamps:
00:28 Intro
01:54 Episode Starts. Starting at Everest Detection and developing a early detection blood-based lung cancer test
05:04 Learning to work with scientists and experiencing a non-iterative business cadence that is more like a rifle shot
07:19 How David approaches projects where you do not have as much room for error or experimentation
10:01 Difference in how software and life science companies think about product market fit
14:30 Using parallel experiments to optimize your learnings rather than just, swapping chairs on the titanic
16:19 The difference in mentality of raising money in a software company vs a biotech company and why money is a super power
18:34 How the size and scale of your business changes how you view your preclinical tests
19:08 Outro
Find Our Guest, David Li, at these links:
Find Our Host, Jon Chee, at these links:
Social & Website
LinkedIn: https://www.linkedin.com/company/excedr/
Youtube: https://www.youtube.com/@excedr
Instagram: https://www.instagram.com/excedr_inc
Twitter: https://twitter.com/ExcedrInc
Facebook: https://www.facebook.com/excedr
TikTok: https://www.tiktok.com/@excedr
Podcast Website: https://www.thebiotechstartupspodcast.com/
Enriched Notes
Topics Mentioned:
Everest Detection https://everestdetection.com/
Meliora Therapeutics https://www.melioratherapeutics.com/
Marketing & Sales Strategies for Startups https://www.excedr.com/blog/marketing-sales-strategies-for-biotechs
Lab Equipment for Biochemistry Research https://www.excedr.com/blog/lab-equipment-list-for-biochemistry-research
Strategies for Better Cash Flow Management https://www.excedr.com/blog/cash-flow-management-strategies
How do Core Labs Support Life Science Research? https://www.excedr.com/blog/core-labs
People Mentioned
Brian Slingerland https://www.linkedin.com/in/brian-slingerland-a7a14b35/
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so
76 odcinków
MP3•Źródło odcinka
Manage episode 427933279 series 3461709
Treść dostarczona przez Jon Chee. Cała zawartość podcastów, w tym odcinki, grafika i opisy podcastów, jest przesyłana i udostępniana bezpośrednio przez Jon Chee lub jego partnera na platformie podcastów. Jeśli uważasz, że ktoś wykorzystuje Twoje dzieło chronione prawem autorskim bez Twojej zgody, możesz postępować zgodnie z procedurą opisaną tutaj https://pl.player.fm/legal.
As a podcast listener, you can redeem exclusive discounts with a growing list of biotech vendors and get $500 off your first equipment lease by using promo code “TBSP” on https://www.excedr.com/rewards.
Part 3 of 4.
My guest for this week’s episode is David Li, CEO and co-founder of Meliora Therapeutics. Meliora's goal is to develop life-saving cancer therapies using cutting-edge science and machine learning. The company derives a comprehensive picture of how drugs interact with cancer biology by combining biofunctional readouts from numerous modalities using advanced machine learning and other computational techniques.
Before Meliora, David served as Chief Business Officer at Everest Detection, an early detection liquid biopsy startup, and was head of commercial operations at Benchling, a life sciences software platform company which has achieved a $6 billion valuation and has attracted over $500 million in funding from firms such as Altimeter Capital, Tiger Global, Lone Pine Capital, Benchmark, Sequoia, Excel, Lux, and numerous others. David began his career in Goldman Sachs Healthcare Investment Banking Group and KKR's Private Equity Group, where he advised and invested in transactions worth over $10 billion in enterprise value. David's multifaceted experiences in the financial and life science sectors give him a wide range of experiences that founders can learn from.
Join us this week and hear about:
- Working at Everest Detection and developing a blood-based lung cancer test
- Excelling in a non-iterative work environment
- How software and biotech companies think about product market fit differently
- Why money is a super power for biotech startups today
- And much more!
Please enjoy my conversation with David Li.
Timestamps:
Timestamps:
00:28 Intro
01:54 Episode Starts. Starting at Everest Detection and developing a early detection blood-based lung cancer test
05:04 Learning to work with scientists and experiencing a non-iterative business cadence that is more like a rifle shot
07:19 How David approaches projects where you do not have as much room for error or experimentation
10:01 Difference in how software and life science companies think about product market fit
14:30 Using parallel experiments to optimize your learnings rather than just, swapping chairs on the titanic
16:19 The difference in mentality of raising money in a software company vs a biotech company and why money is a super power
18:34 How the size and scale of your business changes how you view your preclinical tests
19:08 Outro
Find Our Guest, David Li, at these links:
Find Our Host, Jon Chee, at these links:
Social & Website
LinkedIn: https://www.linkedin.com/company/excedr/
Youtube: https://www.youtube.com/@excedr
Instagram: https://www.instagram.com/excedr_inc
Twitter: https://twitter.com/ExcedrInc
Facebook: https://www.facebook.com/excedr
TikTok: https://www.tiktok.com/@excedr
Podcast Website: https://www.thebiotechstartupspodcast.com/
Enriched Notes
Topics Mentioned:
Everest Detection https://everestdetection.com/
Meliora Therapeutics https://www.melioratherapeutics.com/
Marketing & Sales Strategies for Startups https://www.excedr.com/blog/marketing-sales-strategies-for-biotechs
Lab Equipment for Biochemistry Research https://www.excedr.com/blog/lab-equipment-list-for-biochemistry-research
Strategies for Better Cash Flow Management https://www.excedr.com/blog/cash-flow-management-strategies
How do Core Labs Support Life Science Research? https://www.excedr.com/blog/core-labs
People Mentioned
Brian Slingerland https://www.linkedin.com/in/brian-slingerland-a7a14b35/
The Biotech Startups Podcast is handcrafted by our friends over at: fame.so
76 odcinków
Alle episoder
×Zapraszamy w Player FM
Odtwarzacz FM skanuje sieć w poszukiwaniu wysokiej jakości podcastów, abyś mógł się nią cieszyć już teraz. To najlepsza aplikacja do podcastów, działająca na Androidzie, iPhonie i Internecie. Zarejestruj się, aby zsynchronizować subskrypcje na różnych urządzeniach.